The Netherlands join the list of countries to suspend the use of Oxford-Astrazeneca vaccines due to concerns about possible side effects.
The Dutch government said the move, which will last until at least 29 March, was a precaution, BBC News reports.
The Republic of Ireland earlier made a similar decision over reports of blood clotting in recipients in Norway.
But the World Health Organization says there is no indication of a link between the vaccine and blood clots.
The announcements by the Netherlands and Ireland followed similar moves by Denmark, Norway, Bulgaria, Iceland and Thailand.
The European Medicines Agency (EMA) which is currently carrying out a review into incidents of blood clots says the vaccine’s benefits continue to outweigh its risks.